Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Leprosy
100%
Leprosy Patients
41%
Indonesia
37%
Erythema Nodosum Leprosum
25%
Leprosy Reactions
23%
Disability
23%
Surabaya
22%
Foot Ulcer
22%
Mycobacterium Leprae
18%
Randomized Controlled Trial
17%
Surabaya Indonesia
17%
Adipose-derived Mesenchymal Stem Cells (ADMSCs)
16%
Mesenchymal Stem Cell-conditioned Medium
16%
Risk Factors
16%
Ulcer
14%
Growth Factors
14%
COVID-19
11%
Phenolic Glycolipids
11%
Epidemiology
11%
Gresik
11%
Methotrexate
11%
Prednisolone
11%
Psoriasis Vulgaris
11%
M. Leprae
10%
Grade 2 Disability
10%
India
9%
M. Lepromatosis
9%
Outpatient Clinic
9%
Dr. Soetomo General Academic Hospital
9%
Healing
9%
Venereology
8%
Diffuse Lepromatous Leprosy
8%
Corticosteroids
7%
Bacterial Index
7%
Endemic Countries
7%
Early Detection
7%
Co-infection
6%
Pathological Findings
6%
Gauze Dressing
6%
Tertiary Hospital
6%
Clinical Manifestations
6%
Disability Grade
6%
Steroid Therapy
6%
Clinical Features
5%
Family Members
5%
Psychological Well-being
5%
Referral Center
5%
Conditioned Medium
5%
Hepar
5%
Lycopersicon Esculentum
5%
Medicine and Dentistry
Hansen's disease
83%
Erythema Nodosum Leprosum
24%
Plantar Ulcer
20%
Retrospective Study
20%
Randomized Controlled Trial
18%
COVID-19
16%
Mesenchymal Stem Cell
16%
Outpatient
14%
Ulcer
13%
Cohort Effect
11%
Methotrexate
11%
Prednisolone
11%
Amnion
11%
Infection
10%
Mycobacterium leprae
9%
Dermatology
8%
Venereology
8%
Corticosteroid
8%
Mixed Infection
7%
Prevalence
7%
Metabolite
6%
Cross Sectional Study
6%
Pediatrics
5%
Stem Cell
5%
Lepromatous Leprosy
5%
Randomized Clinical Trials
5%
Patient Referral
5%
Histopathology
5%
Urticaria
5%
Disseminated Herpes Zoster
5%
Framycetin
5%
Placenta
5%
Lopinavir/Ritonavir
5%
Adipose Tissue
5%
Hypertension
5%
Adipocyte
5%
Erythema
5%
Pyoderma
5%
Athlete's Foot
5%
Mouth Infection
5%
Psoriasis Vulgaris
5%
Clinical Feature
5%
Ascorbic Acid
5%
Alpha Tocopherol
5%
Cytokine
5%
Pharmacology, Toxicology and Pharmaceutical Science
Hansen's disease
74%
Ulcer
21%
Plantar Ulcer
20%
Retrospective Study
19%
Randomized Controlled Trial
16%
Erythema Nodosum Leprosum
13%
Mycobacterium leprae
11%
Epidemiology
11%
Growth Factor
10%
Diseases
8%
Enzyme-Linked Immunosorbent Assay
7%
Cytokine
7%
Infection
7%
Corticosteroid
6%
Phenolic Glycolipid I
6%
Ascorbic Acid
5%
Tinea pedis
5%
Interleukin 2
5%
Framycetin
5%
Immunoglobulin M
5%
Coronavirinae
5%
Heavy Metal
5%
Borate Sodium
5%
Bacterium
5%
Hypertension
5%
Steroids
5%
Urticaria
5%
Lycopersicon
5%
Alpha Tocopherol
5%
Lopinavir Plus Ritonavir
5%
Hypoxia
5%
Acne
5%
Mixed Infection
5%
Cylindrocarpon
5%
Psoriasis Vulgaris
5%